Style
GARPTurnover
—Orientation
—| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Biomarin Pharmaceutical Inc(BMRN) | 1,431,590 | $81.9M | 17.42% |
| 2 | Gilead Sciences Inc(GILD) | 343,043 | $43.3M | 9.21% |
| 3 | Arcutis Biotherapeutics Inc(ARQT) | 1,089,701 | $28.6M | 6.07% |
| 4 | Madrigal Pharmaceuticals Inc(MDGL) | 52,545 | $28.2M | 6.00% |
| 5 | Bicara Therapeutics Inc(BCAX) | 892,621 | $26.5M | 5.63% |
| 6 | Relmada Therapeutics Inc(RLMD) | 3,655,075 | $25.3M | 5.38% |
| 7 | Trevi Therapeutics Inc(TRVI) | 1,339,212 | $25.0M | 5.31% |
| 8 | Pharvaris N V(PHVS) | 677,879 | $23.4M | 4.98% |
| 9 | Xenon Pharmaceuticals Inc(XENE) | 367,900 | $22.2M | 4.72% |
| 10 | ANI Pharmaceuticals Inc(ANIP) | 233,808 | $19.4M | 4.11% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 97.62% | 93.25% | -4.37% |
| Unclassified | 2.38% | 6.75% | +4.37% |
Quarter-over-quarter weight changes by market cap
Quarter-over-quarter position changes
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Small Cap | 44.89% | 37.03% | -7.86% |
| Large Cap | 29.83% | 36.58% | +6.75% |
| Mid Cap | 21.57% | 16.61% | -4.96% |
| Unclassified | 2.38% | 6.75% | +4.37% |
| Micro Cap | 1.33% | 3.04% | +1.71% |